Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building
January 29, 2026Research and Development Barts Health NHS Trust, H.I.G. Realty, health innovation
Barts Health NHS Trust and H.I.G. Realty have announced a collaboration to launch an applied healthcare innovation building in the …
Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US
January 29, 2026Head of Business Development US, Rentschler Biopharma
Rentschler Biopharma has announced the appointment of Detra Glinatsis as Head of Business Development US. Glinatsis brings more than two …
Five Facts about spinal muscular atrophy
January 28, 2026Medical Communications Five Facts, Neurology, early diagnosis, five types, gene therapy, muscle weakness, spinal muscular atrophy
1 Spinal muscular atrophy (SMA) is a genetic disease involving the loss of motor neurons in the spinal cord.1 Its …
Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases
January 28, 2026Aspaveli, European Commission, Nephrology, sobi
Sobi has announced that its Aspaveli (pegcetacoplan) has received approval from the European Commission (EC) for the treatment of two …
Everdrone appoints David Borkmann as Senior Medical Advisor
January 28, 2026Everdrone, senior medical advisor
Everdrone, a provider of autonomous drone systems for use in healthcare and emergency response, has announced the appointment of David …
MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance
January 27, 2026FDA, Gastrointestinal tract, MRM Health, ulcerative colitis
Microbial Resource Management (MRM) Health has announced that its lead programme, MH002, has received Investigational New Drug (IND) clearance from …
Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer
January 27, 2026Crystalys Therapeutics, chief financial officer
Crystalys Therapeutics has announced the appointment of Justin Thacker as Chief Financial Officer (CFO). Thacker has spent over 20 years …
Rentschler Biopharma appoints Uwe Buecheler as interim CEO
January 26, 2026Rentschler Biopharma, interim CEO
Rentschler Biopharma, a contract development and manufacturing organisation (CDMO) specialising in biopharmaceutical products, has announced the appointment of Uwe Buecheler …
Sandoz’ Ondibta receives European Commission approval for diabetes
January 26, 2026Research and Development Diabetes, Ondibta, Sandoz
Sandoz has announced that its Ondibta (insulin glargine) has received approval from the European Commission (EC) for the treatment of …
Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation
January 22, 2026Research and Development Complement Therapeutics, FDA, Opthalmology, geographic atrophy
Complement Therapeutics has announced that CTx001, its gene therapy treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD), …
PSI appoints David Allen as Country Manager for Canada
January 22, 2026Country Manager for Canada, PSI
PSI, a contract research organisation (CRO) with a focus on clinical trial delivery, has announced the appointment of David Allen …
Qureight appoints Steven Bishop as Chief Medical Officer
January 21, 2026Qureight, chief medical officer
Qureight has announced the appointment of Dr Steven Bishop as its new Chief Medical Officer (CMO). Bishop previously held the …
Pierre Fabre Laboratories and Iktos announce oncology collaboration
January 21, 2026Research and Development Iktos, Oncology, Pierre Fabre Laboratories
Pierre Fabre Laboratories and Iktos have announced a new collaboration intended to discover and develop new small-molecule drug candidates for …
Qureight appoints Rebecca Simmons as Chief Operating Officer
January 20, 2026Qureight, chief operating officer
Qureight has announced the appointment of Rebecca Simmons as Chief Operating Officer (COO). Simmons brings more than two decades of …
European Medicines Agency recommended 104 medicines for approval in 2025
January 20, 2026Research and Development European Medicines Agency, Rare Diseases
The European Medicines Agency (EMA) has announced data from 2025 showing that over the course of the year it recommended …
Spike in searches relating to spinal muscular atrophy following Jesy Nelson disclosure
January 19, 2026Medical Education Neurology, spinal muscular atrophy
New research from the Centre for Surgery has shown a significant rise in Google searches relating to spinal muscular atrophy …
Biogen’s high-dose Spinraza regimen receives European Commission approval for spinal muscular atrophy
January 19, 2026Research and Development Biogen, Neurology, Spinraza, spinal muscular atrophy
Biogen’s Spinraza (nusinersen) has received approval from the European Commission (EC) as a new high-dose regimen for the treatment of …
Alto Neuroscience announces new patent for depression treatment
January 15, 2026Sales and Marketing Alto Neuroscience, Psychiatry, depression
Alto Neuroscience, a clinical-stage biopharmaceutical company specialising in precision treatments for neuropsychiatric conditions, has announced the issuance of a US …
Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech
January 15, 2026Sales and Marketing Arkin Capital, biotech
Arkin Capital has announced the closing of Arkin Bio Ventures III, a $100m fund designed to invest in pre-clinical and …
Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project
January 14, 2026Research and Development Bio-Sourcing, Oncology, Zerion Pharma, breast cancer
Bio-Sourcing and Zerion Pharma have announced that their collaboration to develop an oral form of the monoclonal antibody trastuzumab for …
